Overview

Catheter Ablation Versus Antiarrhythmic Drugs for Outflow Tract Ventricular ARrhythmias

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
A randomized, parallel, open study comparing catheter ablation versus antiarrhythmic drugs for outflow tract ventricular arrhythmias
Phase:
Phase 4
Details
Lead Sponsor:
Ospedale San Donato
Treatments:
Anti-Arrhythmia Agents
Flecainide
Propafenone
Sotalol